May 09, 2022
Heart failure patients implanted with Barostim can now receive conditional MRI scans MINNEAPOLIS, May 09, 2022 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), developer of the world’s first FDA-approved neuromodulation … Continued
May 09, 2022
NEWS PROVIDED BY Delfi Diagnostics Clinical trial sites selected to enroll diverse populations most affected by lung cancer BALTIMORE, May 9, 2022 /PRNewswire/ — Delfi Diagnostics, a pioneering developer of next generation … Continued
May 05, 2022
–Avéli™ is FDA Cleared and Now Available through a Controlled Commercial Launch to Deliver Women with Cellulite Visibly Meaningful Results in a Single, In-Office Procedure– May 05, 2022 08:00 AM … Continued